The antibody response to Epstein-Barr virions is altered in multiple sclerosis

J W Lindsey1, U Khan, W Ansari

  • 1Department of Neurology, University of Texas Health Science Center at Houston, 6431 Fannin Street, Suite 7.044, Houston, TX 77030, United States. John.w.lindsey@uth.tmc.edu

Insights

Patients with multiple sclerosis (MS) show an increased antibody response to Epstein-Barr virus (EBV) antigens. This study found altered antibody specificity to EBV in MS patients, suggesting a link between EBV and MS pathogenesis.

Area of Science:

  • Neuroimmunology
  • Virology
  • Immunology

Background:

  • Epstein-Barr virus (EBV) infection is linked to multiple sclerosis (MS).
  • Patients with MS exhibit heightened antibody responses to specific EBV antigens.
  • The full spectrum of EBV antigens is not yet completely understood.

Purpose of the Study:

  • To investigate alterations in the antibody response to Epstein-Barr virus (EBV) in patients with multiple sclerosis (MS).
  • To determine if MS is associated with a modified antibody profile against EBV antigens.

Main Methods:

  • Enzyme-linked immunosorbent assay (ELISA) was used to measure antibodies in serum and cerebrospinal fluid (CSF).
  • Western blot analysis was employed to identify specific EBV antigens recognized by antibodies.
  • Antibody levels and specificities were compared between MS patients and controls.

Main Results:

  • Antibodies to EB virions were elevated in both serum and CSF of individuals with MS.
  • Western blot analysis revealed that MS patients recognized multiple distinct EBV antigens.
  • A generally higher antibody response to all EBV antigens was observed in MS patients, with notable increases against certain antigens.

Conclusions:

  • The antibody response to EBV in MS patients is generally increased.
  • There is evidence of altered specificity in the antibody response to EBV among individuals with MS.
  • These findings suggest a significant immunomodulatory role of EBV in the pathogenesis of multiple sclerosis.

Related Concept Videos

Cross-reactivity00:42

Cross-reactivity

Overview
Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Humoral Immune Responses01:36

Humoral Immune Responses

Overview
B Cell Activation and Differentiation01:24

B Cell Activation and Differentiation

The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...